196 related articles for article (PubMed ID: 18598958)
1. Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
Sicouri S; Glass A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2008 Jul; 5(7):1019-26. PubMed ID: 18598958
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.
Sicouri S; Blazek J; Belardinelli L; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):371-9. PubMed ID: 22407414
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves.
Sicouri S; Carlsson L; Antzelevitch C
J Pharmacol Exp Ther; 2010 Jul; 334(1):255-9. PubMed ID: 20360353
[TBL] [Abstract][Full Text] [Related]
4. Effect of autonomic influences to induce triggered activity in muscular sleeves extending into the coronary sinus of the canine heart and its suppression by ranolazine.
Sicouri S; Belardinelli L; Antzelevitch C
J Cardiovasc Electrophysiol; 2019 Feb; 30(2):230-238. PubMed ID: 30302862
[TBL] [Abstract][Full Text] [Related]
5. Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations.
Sicouri S; Belardinelli L; Carlsson L; Antzelevitch C
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):803-10. PubMed ID: 19298559
[TBL] [Abstract][Full Text] [Related]
6. Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
Sicouri S; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Heart Rhythm; 2012 Mar; 9(3):422-9. PubMed ID: 22019863
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeve preparations.
Sicouri S; Cordeiro JM; Talarico M; Antzelevitch C
J Cardiovasc Electrophysiol; 2011 Jun; 22(6):698-705. PubMed ID: 21159010
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation.
Sicouri S; Antzelevitch C
Electrofisiol Arritm; 2010 Oct; 3(4):108-113. PubMed ID: 24999375
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations.
Sicouri S; Gianetti B; Zygmunt AC; Cordeiro JM; Antzelevitch C
J Am Coll Cardiol; 2011 Feb; 57(8):986-93. PubMed ID: 21329846
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967.
Sicouri S; Belardinelli L; Antzelevitch C
Heart Rhythm; 2013 Jul; 10(7):1036-43. PubMed ID: 23524321
[TBL] [Abstract][Full Text] [Related]
11. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
Burashnikov A; Belardinelli L; Antzelevitch C
J Pharmacol Exp Ther; 2012 Jan; 340(1):161-8. PubMed ID: 22005044
[TBL] [Abstract][Full Text] [Related]
12. Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria.
Sicouri S; Burashnikov A; Belardinelli L; Antzelevitch C
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):88-95. PubMed ID: 19952329
[TBL] [Abstract][Full Text] [Related]
13. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
[TBL] [Abstract][Full Text] [Related]
14. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.
Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
Circulation; 2007 Sep; 116(13):1449-57. PubMed ID: 17785620
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
Burashnikov A; Di Diego JM; Barajas-Martínez H; Hu D; Cordeiro JM; Moise NS; Kornreich BG; Belardinelli L; Antzelevitch C
Circ Heart Fail; 2014 Jul; 7(4):627-33. PubMed ID: 24874201
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.
Burashnikov A; Sicouri S; Di Diego JM; Belardinelli L; Antzelevitch C
J Am Coll Cardiol; 2010 Oct; 56(15):1216-24. PubMed ID: 20883928
[TBL] [Abstract][Full Text] [Related]
17. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
Antzelevitch C; Belardinelli L; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Thomas G
Circulation; 2004 Aug; 110(8):904-10. PubMed ID: 15302796
[TBL] [Abstract][Full Text] [Related]
19. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes.
Song Y; Shryock JC; Belardinelli L
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2031-9. PubMed ID: 18310511
[TBL] [Abstract][Full Text] [Related]
20. Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model.
Sossalla S; Wallisch N; Toischer K; Sohns C; Vollmann D; Seegers J; Lüthje L; Maier LS; Zabel M
Cardiovasc Ther; 2014 Aug; 32(4):170-7. PubMed ID: 24785406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
